Your Health Plan Buyer Is Cutting Providers. Here's What That Changes About Your Deal.
Health plans are tightening their provider networks across MA, Medicaid, and commercial. Here's what's driving it, what it's doing to your sales cycle, and where the buying opportunities are.
Upward Growth provides health tech leaders with the playbooks and proof to transform complex markets into real growth. Each week, we deliver clear, practical strategies on positioning, messaging, and growth, so leaders can close enterprise deals and build repeatable momentum.
🤝 Work with Ryan on payor growth strategy: Contact me
🟦 Connect with the author, Ryan Peterson, on LinkedIn.
📰 Newsletter sponsorships are available: Learn More
Charm Economics is a boutique healthcare economics and policy consulting firm that translates complex data into clear, decision-ready insights for industry leaders. Our team brings decades of experience in health policy analysis, data analytics, and mixed-methods research.
Our work includes ROI modeling to quantify the financial value of new healthcare technologies, economic impact analysis of policy proposals, and expert witness support with damages modeling and policy simulations.
By combining rigorous research with practical economic analysis, Charm helps organizations turn health economic evidence into measurable impact.
Contact us to understand your value pathways to measurable ROI today.
Interested in sponsoring Upward Growth? Learn more
Health plans are cutting providers. If you sell to those plans, the fallout is already in your pipeline.
More than a dozen major health systems dropped Medicare Advantage contracts for 2026. UnitedHealthcare exited 225 counties. Humana exited 198. KFF reports that 2.6 million MA enrollees are in terminated plans, double the prior year's figure. Medicaid MCOs are narrowing networks as states respond to federal funding cuts under the One Big Beautiful Bill. Commercial plans are tightening provider panels to control employer premium increases hitting 15-year highs. Underneath all of it, network management teams at plans of every size are running provider-by-provider evaluations and deciding who stays and who gets a termination letter.
Your buyer is the one making those cuts, and the process is consuming time, budget, and attention across the organization. The plan you've been selling to for six months just restructured its provider network. Even if your champion isn't directly managing termination disputes and member reassignment, the people around them are, and it's pulling leadership focus, internal resources, and budget away from vendor evaluations and toward network stabilization and compliance remediation. That's why your Q1 slowed down, and nobody inside the plan told you that was the reason.
This pattern has come up in nearly every conversation I’ve had over the past several weeks, with PE investors, portfolio company CEOs, and health tech sales leaders. Provider-side companies are losing payor contracts they assumed were stable. Health tech vendors are watching deals stall without explanation. Investors are trying to figure out whether this is a temporary cycle or something structural. When you're selling to one health plan, a stalled deal looks like your problem. When you're hearing the same story from a dozen different directions across provider services and health tech, it stops looking like bad luck and starts looking like a market shift. That broader view is part of what I wanted to bring into this piece, because even if you're running a single sales team at a single company, it helps to know this isn't a slow quarter. It's a structural change in how your buyers are operating.
[If you're a health tech investor seeing this play out across your portfolio, I'd love to hear what you're seeing. I'm building on this topic over the coming months and the best insights I get come from people living it across multiple companies. Shoot me a note.]
Quick note for the regular readers: I'm prepping for RISE National next week (be sure to say hello!) while simultaneously working on a pretty significant marketing and brand buildout for Upward Growth. For years, we’ve been so focused on client work, positioning, go-to-market, payor strategy for other companies, that we never really spent much time on our own brand. We’ve stayed busy through word of mouth, and I owe a real thanks to the clients and readers who’ve trusted us and referred us over the years. There’s something a little funny about spending years helping health tech companies tell their story while barely telling your own. That’s changing this year.
This article breaks down what’s happening inside your buyer’s organization right now, what network narrowing is doing to your sales cycle, and where the buying opportunities are for vendors who understand the shift. There’s also a section for provider-side businesses and the investors who back them, because the same dynamic reshaping your buyer’s behavior is putting portfolio company revenue at risk. Let's get into it.
What Network Narrowing Actually Looks Like Inside Your Buyer’s Organization
When a health plan cuts providers, the operational work that follows lands on every department your sales process runs through.
Network management evaluates providers across five dimensions before making termination decisions: adequacy math, cost benchmarking, quality performance, administrative friction and fraud risk, and strategic alignment. Adequacy gaps need to be modeled and addressed. Terminated providers file disputes and grievances. Members who lost their doctor need to be reassigned and notified. Provider directories need to be updated and verified, especially now that CMS has finalized rules requiring MA plans to make directory data available through Medicare Plan Finder. Plans that listed providers as in-network in their directories when those providers weren't actually available to see members are now getting caught. That's accelerating the cleanup and triggering even more terminations.
Compliance pressure is compounding all of it. The OIG published its first major Medicare Advantage compliance program guidance update since 1999 in February 2026, and the DOJ’s 2025 National Health Care Fraud Takedown charged 324 defendants tied to $14.6 billion in alleged fraud. Plans are narrowing networks to reduce costs and simultaneously cleaning house as a program-integrity exercise, cutting providers with coding anomalies, billing red flags, or compliance gaps, even when cost and quality metrics look acceptable. That means two different types of termination work, cost-driven and compliance-driven, running through the same departments at the same time.
The people you’re selling to are in the middle of all of it. Network management is most directly consumed, but compliance is responsible for reviewing every termination for regulatory exposure, while legal processes provide dispute resolution. Operations is handling member reassignments and the resulting spike in call volume. Finance is redirecting budget toward stabilization. Clinical leadership is trying to maintain care continuity and quality scores with a smaller provider panel, and that job just got harder because fewer in-network providers mean each one’s HEDIS performance and Stars impact carries more weight.
Network adequacy math is the factor most vendors miss, and it’s the one driving more of these decisions than anything else. Before a plan terminates a provider, network management runs a time-and-distance analysis against CMS requirements: can we meet adequacy standards in this geography and specialty without this provider? If yes, the provider is expendable regardless of tenure, volume, or outcomes.
That’s where vendor opportunity opens up. If your solution helps plans fill the adequacy gaps that cuts create (telehealth, virtual specialty access, digital behavioral health, care navigation that routes members to remaining providers), your budget category just shifted from discretionary to compliance. CMS added outpatient behavioral health as a facility specialty type for network adequacy evaluation in 2026 with a 10% telehealth credit, giving digital behavioral health solutions a regulatory hook that didn’t exist a year ago. And in rural markets, where Johns Hopkins research projects roughly 2.9 million MA enrollees facing forced disenrollment, rural areas are disproportionately affected, and plans need virtual and remote solutions to meet CMS requirements.
If a plan can meet network adequacy without a provider, that provider has zero leverage regardless of tenure or volume. For vendors, the inverse is the opportunity: if your solution helps a plan meet adequacy after a round of cuts, you just became essential.
Six months ago, your deal competed with other vendors. Right now, it's competing with adequacy gaps, compliance remediation, and member fallout, and those problems have regulatory deadlines your deal doesn't. That reality is part of the broader de-risking trend reshaping how plans evaluate both vendors and providers in 2026, and it's already showing up in how fast your deals are moving.
What Health Plan Network Restructuring Did to Your Q1 Pipeline
Your pipeline slowed in Q1, and you probably chalked it up to the usual reasons. Budget cycles resetting, new priorities getting sorted, buyers finding their footing after the holidays. But that may not be the full story.
Here's what changed inside the plan you've been selling to. They spent January and February managing the fallout from network decisions they finalized in Q4. Termination notices went out, provider disputes started landing, member complaint volume spiked, and directory cleanup projects pulled staff away from everything else for weeks. All of it hit at once, leaving little room to evaluate new vendors.
Your contacts inside the plan are harder to reach, slower to respond, and less focused on your deal than they were six months ago. The budget earmarked for new vendor initiatives may have been redirected to network stabilization, compliance remediation, and member retention. If your deal isn’t tied to one of these priorities, it may be on hold for a while.
And March 31 will make this worse. That’s the date the CMS Interoperability and Prior Authorization final rule requires MA plans to begin publicly reporting, for the first time, prior authorization data on their websites: approval rates, denial rates, average decision times, and appeals outcomes. Every plan in the country is preparing to have those numbers visible to regulators, members, competitors, and the press. Even if your solution has nothing to do with prior auth, the compliance and operations teams inside your buyer’s organization are preparing that data for public posting, auditing prior auth workflows, and managing the reputational risk of what those numbers will show. I wrote about how the prior auth deadline is affecting vendors who don’t sell prior auth a few weeks ago. Network restructuring and prior auth reporting prep are pulling from the same people and hours within the plan, and your deal doesn’t have a regulatory deadline that forces it to the top of anyone’s list.
So the question becomes: how do you know which plans are in the middle of this and which ones aren't? The qualification question that separates vendors who adjusted from vendors who are still guessing is simple: "Is this plan currently expanding, maintaining, or narrowing its network?"
The answer reshapes how you read every deal in your pipeline. If they’re narrowing, your timeline just extended by two to three months unless you can tie your solution to one of the problems the narrowing created. If they’re maintaining, you’re in a normal cycle. If they’re expanding into markets the nationals abandoned, they’re actively investing, and your deal may be better positioned than you think. How to surface that answer without asking directly, and when to time your outreach around it, is what we’ll cover after the paywall.
A Note for Provider-Side Businesses and the Investors Who Back Them
This section is for the PE investors and portfolio company operators I’ve been talking to over the past several weeks, as well as for any provider-side CEO or COO reading this. If you’re a vendor reader, stay with me here. Understanding what your buyers are doing to the provider side of the market sharpens your picture of the pressures shaping every conversation you’re having right now.
Payor relations at most provider organizations is a back-office task handled by whoever also manages credentialing. Check the boxes, submit the paperwork, assume the contract renews because it always has. That assumption is getting people fired.
For many outpatient provider businesses, a single payor contract represents 15 to 40 percent of revenue. Losing one isn’t just a line-item adjustment, it can be existential. PE-backed companies carrying leverage on the balance sheet have even less room to absorb that kind of revenue shock, and in rural markets where plans are exiting counties entirely, the risk compounds further: the buyer isn’t renegotiating your rate, they’re disappearing from your geography.
The providers who survive the cut make it easy for health plans to want to keep them: low administrative friction, clean billing and coding, strong quality data shared proactively, willingness to participate in value-based arrangements, and responsiveness when network management calls. The providers who get cut tend to have something in common too. Nobody at the plan knows them. There's often little to no relationship beyond the claims file, no track record of collaboration, and no reason for network management to fight to keep them when the evaluation comes.
With plans making faster, more informed decisions about which providers to keep, the organizations that treat payor relations as a strategic function will outperform those still treating it as paperwork. For provider-side businesses, that means elevating payor relations to a leadership-level function reporting to the provider organization's CEO. The person in this role should be running quarterly business reviews with each major payor, sharing cost and quality performance data before the plan asks for it, and monitoring network adequacy dynamics in their geography so they know when a plan is evaluating their position before anyone sends a letter. That’s fundamentally different from credentialing and contract renewals, and most provider organizations haven’t built it yet.
The pressure on outpatient providers right now is coming from both directions. Revenue cycle management is pushing harder to capture every dollar, and payment integrity teams at plans are pushing just as hard to claw it back. Provider organizations are caught in the middle, and those without a strong payor relationship strategy are most exposed. If that describes your portfolio, this is the function to invest in first.
We’ve covered what’s driving the network narrowing wave, what it’s doing inside your buyer’s organization, and why your Q1 pipeline might have slowed. Below is where plan budgets are actually moving post-narrowing, the discovery questions and timing framework to qualify your deals around it, and the positioning language that connects your solution to what your buyer is solving right now.
Paid subscribers get this, plus 25+ frameworks, scripts, and deep dives built for health tech teams selling to health plans. One qualified conversation from these frameworks is worth more than a decade of subscriptions.
Upgrade to a paid subscription to keep reading.